BRCA2 and ovarian neoplasm: Interestingly, our analysis of the BRCA2-mutant ovarian tumor dataset revealed that tumors with high APOBEC3 levels (combined A3A and A3B) and low APE1 expression were associated with the worst overall survival compared to all other combinations (Fig. 9m).